Anagram

Anagram

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.goanagram.com/

Last Round

Series A

Feb 26, 2025

Total Funding Raised

$25.38M

Company Overview

Anagram is a financial software company that provides a unified revenue cycle management SaaS platform that automates vision insurance billing and claims management for eye care providers.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Revenue Cycle, InsurTech

Business Model

B2B

Customer Profile

Subscription SaaS, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

revenue cycle managementRCMeye care softwaremedical billing servicesvision insuranceoptometry softwaremanaged billing servicesoutsourced billinginsurance verificationclaim submissiondenial managementout-of-network billingophthalmology softwareoptical billingpayment postingrevenue share billingvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anagram Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Anagram Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 26, 2025
Series AFeb 26, 2020
SeedAug 15, 2019

Key People

Founding team and executive leadership

Jeremy Bluvol

CEO

Executive Team

Anagram Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    Processes hundreds of millions of dollars in eye care billing annually.

  • Mar 13, 2026

    Over 2,000 eye care professionals now use the platform.

Anagram Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anagram Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anagram's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range92
Year Founded2014
Last FundingFeb 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.